Secondary Logo

Institutional members access full text with Ovid®

Joint and soft-tissue injections in rehabilitation inpatients taking direct oral anticoagulants

Nord, Hunter M.a; Journeay, W. Shaneb,,c; Lipson, David M.b,,c

International Journal of Rehabilitation Research: June 2019 - Volume 42 - Issue 2 - p 187–189
doi: 10.1097/MRR.0000000000000330
Brief Research Reports

The risk for complications associated with joint and soft-tissue injections in patients taking direct oral anticoagulants (DOACs) is not fully understood. In this retrospective evaluation of 445 inpatients in a rehabilitation hospital who received corticosteroid injections, complications were compared in patients on DOACs with those who were not. After a review of all injections, no adverse events of significant bleeding (intra-articular or extra-articular) were observed. These findings suggest no substantial increase in adverse events associated with the use of DOACs when performing joint and soft-tissue injection procedures in inpatient rehabilitation setting.

aDepartment of Kinesiology, McMaster University

bProvidence Healthcare

cDepartment of Medicine, Division of Physical Medicine and Rehabilitation, University of Toronto, Ontario, Canada

Received 26 September 2018 Accepted 11 November 2018

Correspondence to David Lipson, MD, FRCPC, Providence Healthcare, 3276 St Clair Avenue, East Toronto, ON, Canada M1L 1W1 Tel: +1 416 285 3619; fax: +1 416 285 3764; e-mail:

Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.